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Objective: Pleural tuberculosis (TB) is a diagnostic challenge because of its non-speciﬁc clinical
presentation and paucibacillary nature. Conventional diagnosis methods have limitations.We evaluated
the real-time polymerase chain reaction (PCR), interferon-gamma (IFN-g), adenosine deaminase (ADA),
and immunoglobulin A (IgA).
Methods: We assessed 204 cases: 50 were conﬁrmed pleural TB, 104 were probable pleural TB, and 50
formed the non-TB group. IFN-g and IgA were measured by enzyme-linked immunosorbent assay and
ADA was measured by colorimetric assay. Real-time PCR was carried out using the 16S rRNA sequence,
pleural biopsy specimens were submitted to histopathologic examination, pleural ﬂuid culture was
undertaken using Lowenstein–Jensen and MGIT-BACTEC, and pleural ﬂuid smears were stained with
auramine O.
Results: For conﬁrmed and probable pleural TB cases, the area under the curve (AUC) of the receiver
operating characteristic (ROC) curve was highest for IFN-g (0.994 and 0.963, respectively), followed by
ADA (0.989 and 0.945, respectively), real-time PCR (0.898 and 0.784, respectively), and IgA (0.817 and
0.784, respectively). For conﬁrmed and probable pleural TB cases, IFN-g showed the highest sensitivity
(98% and 76.9%, respectively), followed by ADA (92% and 73%, respectively), real-time PCR (80% and
57.7%, respectively), and IgA (70% and 57.7%, respectively). With regard to combined positivity, the
combination of ‘either real-time PCR or IFN-g’ showed the highest sensitivity: 100% in conﬁrmed pleural
TB and 96.2% in probable pleural TB.
Conclusions: IFN-g showed the highest sensitivity as an individual diagnostic test. When a combination
of tests was used, positivity of ‘either IFN-g or real-time PCR’ appeared valuable for the diagnosis of
pleural TB.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Tuberculosis (TB) remains a major cause of morbidity and
mortality, and represents the most frequent cause of death by a
single infectious agent worldwide.1 Globally, the proportion of
extrapulmonary TB (EPTB) cases reported from various countries
ranges from 15% to 25%,2 with greater proportions occurring in
countries with a high prevalence of human immunodeﬁciency
virus (HIV) infection.3
Pleural TB is a common manifestation of EPTB; it constitutes a
frequent clinical problem4 and is particularly important in the
present era of co-infection with HIV.5 Pleural TB accounts for 3.3–
4.0% of TB cases in the USA.6 Conventional diagnostic tests for* Corresponding author. Tel.: +91 0 930 2124512; fax: +91 0 731 2470068.
E-mail address: ds_chitnis@rediffmail.com (D.S. Chitnis).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2010.11.011pleural TB include microscopic examination of the pleural ﬂuid,
culture of pleural ﬂuid or pleural tissue, and histopathological
examinations. These tests have recognized limitations in clinical
use,7 so new and more rapid diagnostic tests are needed.8
The quantiﬁcation of interferon-gamma (IFN-g) has shownhigh
sensitivity and speciﬁcity in pleural TB,9–12 and the measurement
of adenosine deaminase (ADA) levels has been proved to have high
sensitivity and reasonable speciﬁcity for pleural TB.11–15 Nucleic
acid ampliﬁcation tests such as the polymerase chain reaction
(PCR) and real-time PCR have been used for the detection of pleural
TB and have been shown to have high sensitivity and speciﬁci-
ty.12,13,16–21 Immunoglobulin IgG and IgM antibodies to tubercular
antigen have been explored for the diagnosis of TB, but the
evaluation of IgA type antibodies appears to be inadequate,
especially for pleural TB.13,20
In the present studywe aimed to evaluate IFN-g, ADA, real-time
PCR, and IgA, alongwith acid-fast bacillus (AFB) smear, biopsy, andses. Published by Elsevier Ltd. All rights reserved.
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time PCR, and IgA, along with AFB smear, biopsy, and culture have
not been evaluated previously. Data were compared using receiver
operating characteristic (ROC) curves.
2. Methods
Two hundred and four cases of pleural effusion referred to
Choithram Hospital and Research Center, Indore, Madhya Pradesh,
India, from February 2008 to October 2009, were included in this
prospective study. Of the 204 consecutive cases of pleural effusion,
50 cases were of conﬁrmed pleural TB, 104 cases were of probable
pleural TB, and 50 cases formed the non-TB control group, as
shown in Table 1. The differentiation of pleural effusion into
transudates and exudates was established according to the criteria
of Light et al.21 The studywas approved by the Ethics Committee of
Choithram Hospital and Research Center, which has guidelines
based on the Helsinki Declaration. Written informed consent was
obtained from patients before pleural tap or pleural biopsy
collection.
Three categories of patient with pleural effusion were included
in the study: (1) those with conﬁrmed pleural TB, based on the
conventional gold standard of AFB smear or culture positive for
Mycobacterium tuberculosis from pleural ﬂuid, or histology of
pleural biopsy showing a caseating granuloma; (2) those with
probable pleural tuberculosis, based on clinical signs and
symptoms (cough, fever, chest pain, weight loss) or with raised
pleural ﬂuid lymphocytes and proteins who responded to anti-TB
drugs and with the exclusion of another diagnosis; (3) those with
pleural effusion from a non-TB lung infection with an etiology
different from TB, as shown in Table 1.
2.1. Specimen collection and processing
For each subject 30–40 ml of pleural ﬂuid was collected and
an aliquot of 5–10 ml pleural ﬂuid submitted for cytology,
routine cell count, and biochemistry, including total protein,
albumin, and glucose. The remaining 25–30 ml was centrifuged
at 6000 rpm for 20 min and the supernatant, except for the
bottom 2 ml, decanted out. A 2 ml portion of supernatant was
transferred to a cryovial and preserved at 70 8C for subsequent
IFN-g, ADA, and IgA tests. Simultaneously, a pleural biopsy was
performed and the specimen was submitted for histopathologic
examination. The centrifuged deposit with about 2 ml superna-
tant mixed by vortexing formed the concentrate. An aliquot of
0.5 ml of the concentrated pleural ﬂuid was inoculated over
Lowenstein–Jensen (LJ) slant and MGIT BACTEC tubes containing
7H9 Middlebrook medium. The LJ slants were incubated at 37 8CTable 1
Categories of cases included in the study
Category Male Female Age group, years
Conﬁrmed pleural TB cases (n = 50) 38 12 21–50
Probable pleural TB cases (n = 104) 74 30 24–45
Non-TB cases with pleural effusion
(n = 50)
37 13 23–47
Exudative effusion
Malignancies (n = 12)
Bacterial pneumonia (n = 5)
Pancreatitis (n = 3)
Transudative effusion
Congestive cardiac failure (n = 3)
Rheumatoid arthritis (n = 4)
Cirrhosis (n = 6)
Malignancies (n = 15)
Systematic lupus erythematosis (n = 2)
TB, tuberculosis.for 4–8 weeks and observed weekly. The MGIT BACTEC tubes
were observed on alternate days using an MGIT ﬂuorescence
reader (BD-BBL, USA). Another aliquot of 0.5 ml concentrate was
recentrifuged in microtubes at 6000 rpm for 15 min and the
deposit was used for AFB smear. The smears were stained with
auramine O (Hi-Media, India) and visualized under a ﬂuores-
cence microscope. The remaining 1 ml concentrate was used for
real-time PCR.
2.2. Interferon-gamma
The concentration of IFN-g in pleural ﬂuid was measured by
enzyme-linked immunosorbent assay (ELISA) IFN-g kit (Immu-
notech–Beckman Coulter, Marseille, France). The manufacturer’s
instruction protocol was followed. Brieﬂy, the wells were coated
with monoclonal antibody and IFN-g from patient pleural ﬂuid/
standards allowed to compete with the antibody conjugate. The
results were interpreted by measuring the optical density (OD) at
450 nm in an ELISA reader. The results were calculated by
constructing a standard curve to determine IFN-g concentration
(IU/ml) using the OD value of each sample. The sensitivity of the
ELISA kit for IFN-g was 0.08 IU/ml.
2.3. ADA activity
ADA activity was determined in pleural ﬂuid using the
colorimetric method described by Giusti and Galanti.22 A
positive result was deﬁned as a value 44.75 U/l based on
the cut-off obtained from the ROC curve. A positive control
sample and two negative control samples for which the ADA
values were known were included in each group of clinical
samples analyzed.
2.4. DNA extraction
The DNA was extracted using the Qiagen QIAamp DNA mini kit
(Qiagen, Valencia, CA, USA). Two hundred microliters of sample
were used for the DNA extraction. The DNAwas puriﬁed through a
spin column according to the manufacturer’s recommendations.
The extracted DNA was stored at 20 8C.
2.5. Real-time PCR
The Geno-Sen’s MTB Complex Real-Time PCR kit (Genome
Diagnostics Pvt. Ltd, India) was used for the detection of M.
tuberculosis complex in pleural ﬂuid samples using a real-time
centrifugal ampliﬁcation system (Rotor-Gene 3000, Corbett
Research, Australia). For the assay, 25 ml of reaction mixture
(12.5ml of speciﬁc master mix, 2.5ml of magnesium solution, and
10 ml of sample DNA) was used. The speciﬁc master mix contained
reagents, enzymes, and speciﬁc sequences of the 16S rRNA gene of
M. tuberculosis complex. The reaction protocol was as follows:
initial activation of Hot Start enzyme at 95 8C for 10 min; a 45-cycle
ampliﬁcation phase of 95 8C denaturation for 15 s, a 60 8C
annealing for 20 s, and a 72 8C extension for 15 s. Data analysis
was performed using Rotor-Gene software, according to the
manufacturer’s instructions.
2.6. IgA antibodies against A-60 antigen
IgA antibody to the A-60 antigen of M. tuberculosis was
measured in pleural ﬂuid by the ELISA method using a
commercially available kit (ANDA Biologicals, Strasbourg, France).
The standard protocol23 suggested by the manufacturer was
followed. The results were interpreted by measuring the OD at
450 nm in an ELISA reader.
Figure 2. Comparison of the receiver operating characteristic curves for the
different test parameters in probable pleural tuberculosis.
Table 2
Results for the various individual test parameters among conﬁrmed and probable
pleural TB cases
Patient group Real-time PCR IFN-g ADA IgA
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Data were analyzed using diagnostic test 2  2 contingency
tables to calculate sensitivity, speciﬁcity, positive predictive value
(PPV), negative predictive value (NPV), and likelihood ratios (LR)
with 95% conﬁdence intervals (CI) using StatsDirect statistical
software version 2.7.2 (StatsDirect Ltd, Altrincham, Cheshire, UK).
Differences between various diagnostic methods were measured
using the McNemar Chi-square test (p-values of <0.05 were
considered signiﬁcant). To compare the performance of different
diagnostic tests, ROC curves were also constructed.24
3. Results
3.1. Sensitivity, speciﬁcity, predictive values, likelihood ratios, and
ROC curves for the individual methods
Among the conﬁrmed pleural TB cases, the sensitivity of
microscopic examination for AFB was 28%, of biopsy was 34%, and
of culture was 44%.
For conﬁrmed and probable pleural TB cases, the area under the
curve (AUC) of the ROC curve was highest for IFN-g (0.994 and
0.963, respectively), followed by ADA (0.989 and 0.945, respec-
tively), real-time PCR (0.898 and 0.784, respectively), and IgA
(0.817 and 0.784, respectively) (Figures 1 and 2).
In both conﬁrmed and probable TB, the sensitivity of IFN-gwas
the highest among the different diagnostic parameters (Table 2).
The sensitivity of IFN-g in the conﬁrmed pleural TB group was
signiﬁcantly higher than that of AFB smear, culture, and pleural
biopsy (95% CI, p < 0.0001). IFN-gwas raised in two samples from
the non-TB group. Among conﬁrmed and probable pleural TB cases,
positive likelihood ratios of IFN-g were greater than for ADA and
IgA, however they were lower than for real-time PCR (Table 2).
In the conﬁrmed pleural TB samples, the sensitivity of real-time
PCR was signiﬁcantly higher than that of AFB smear, culture, and
pleural biopsy (95% CI, p < 0.0001); however the sensitivity of real-
time PCR was lower than IFN-g and ADA. Real-time PCR was
positive in one sample from the non-TB group. Real-time PCR
showed higher positive likelihood ratios than IFN-g, ADA, and IgA
for both conﬁrmed and probable pleural TB (Table 2).
The sensitivity of ADA in the conﬁrmed pleural TB group was
signiﬁcantly higher than that of AFB smear, culture, and pleural
biopsy (95% CI, p < 0.0001). The sensitivity of ADA in the
probable pleural TB group was higher than that of real-time PCR
and IgA, but lower than that of IFN-g (Table 2). ADA was positive
in four patients in the non-TB group. The positive likelihood ratioFigure 1. Comparison of the receiver operating characteristic curves for the
different test parameters in conﬁrmed pleural tuberculosis.of ADA was higher than that of IgA, but lower than that of real-
time PCR and IFN-g in both conﬁrmed and probable pleural TB
cases (Table 2).
The sensitivity of IgA in the conﬁrmed pleural TB group was
signiﬁcantly higher than that of AFB smear, culture, and pleural
biopsy (95% CI, p < 0.0001). IgA was positive for seven patients in
the non-TB group. The IgA positive likelihood ratio was the lowest
among the different diagnostic parameters (Table 2).
3.2. Combination of diagnostic methods
The measurement of ‘either IFN-g or real-time PCR’ yielded the
highest sensitivity of 100% in the conﬁrmed pleural TB group and
96.2% in the probable TB group; 94% speciﬁcity was shown in both
the conﬁrmed and probable TB groups (Table 3).
The combination of ‘both IFN-g and ADA’ showed the highest
sensitivity (92%) and speciﬁcity (100%) in the conﬁrmed pleural TB
group among the different parameter combinations, and showed
65.4% sensitivity and 100% speciﬁcity in the probable TB group
(Table 4).Conﬁrmed pleural TB cases
Sensitivity 80% 98% 92% 70%
Speciﬁcity 98% 96% 92% 86%
Positive predictive value 97.6% 96% 92% 83.3%
Negative predictive value 83.1% 98% 92% 74.1%
Positive likelihood ratio 40.2 24.5 11.5 5
Negative likelihood ratio 0.02 0.02 0.1 0.3
Probable pleural TB cases
Sensitivity 57.7% 76.9% 73% 57.7%
Speciﬁcity 98% 96% 92% 86%
Positive predictive value 96.4% 97.6% 95% 89.6%
Negative predictive value 52.7% 66.7% 62.2% 49.4%
Positive likelihood ratio 28.8 19.2 9.1 4.1
Negative likelihood ratio 0.4 0.2 0.3 0.5
Total TB cases (conﬁrmed + probable pleural TB cases)
Sensitivity 64.9% 83.8% 79.2% 61.7%
Speciﬁcity 98% 96% 92% 86%
Positive predictive value 99% 98.47% 96.8% 93.13%
Negative predictive value 47.6% 65.8% 59% 42.2%
Positive likelihood ratio 32.5 20.9 9.9 4.4
Negative likelihood ratio 0.4 0.2 0.2 0.4
TB, tuberculosis; PCR, polymerase chain reaction; IFN-g, interferon-gamma; ADA,
adenosine deaminase; IgA, immunoglobulin A.
Table 3
Results for combinations of ‘either test parameter positive’ among conﬁrmed and probable pleural TB cases
Patient group IFN-g or ADA IFN- g or real-time PCR IFN-g or IgA Real-time PCR or ADA ADA or IgA Real-time PCR or IgA
Conﬁrmed pleural TB
Sensitivity 98% 100% 98% 96% 94% 92%
Speciﬁcity 88% 94% 88% 90% 84% 86%
PPV 89% 94.3% 89% 90.6% 84.3% 86.8%
NPV 97.7% 100% 97.7% 95.7% 93.3% 91.5%
Probable pleural TB
Sensitivity 84.6% 96.2% 77% 94.2% 76.9% 90.4%
Speciﬁcity 88% 94% 88% 90% 84% 86%
PPV 93.2% 97.1% 93% 95.1% 90.9% 93.1%
NPV 73.3% 92.2% 64.7% 88.2% 63.6% 81.1%
Pleural TB total
Sensitivity 88.9% 97.4% 83.7% 94.8% 82.5% 90.9%
Speciﬁcity 88% 94% 88% 90% 84% 86%
PPV 95.8% 98% 95.5% 96.7% 94% 95.2%
NPV 72.1% 92.2% 63.7% 84.9% 60.8% 75.4%
TB, tuberculosis; PCR, polymerase chain reaction; IFN-g, interferon-gamma; ADA, adenosine deaminase; IgA, immunoglobulin A; PPV, positive predictive value; NPV,
negative predictive value.
Table 4
Results for combinations of ‘both test parameters positive’ among conﬁrmed and probable pleural TB cases
Patient group IFN-g+ADA IFN- g+ real-time PCR IFN-g+ IgA Real-time PCR+ADA ADA+ IgA Real-time PCR+ IgA
Conﬁrmed pleural TB
Sensitivity 92% 80% 70% 78% 66% 68%
Speciﬁcity 100% 100% 96% 100% 96% 100%
PPV 100% 100% 94.6% 100% 94.3% 100%
NPV 92.5% 83% 76.2% 82% 73.8% 77.5%
Probable pleural TB
Sensitivity 65.4% 38.5% 57.6% 36.5% 37.5% 26.9%
Speciﬁcity 100% 100% 96% 100% 96% 100%
PPV 100% 100% 96.8% 100% 94.7% 100%
NPV 58.1% 43.9% 52.2% 43.1% 64.7% 39.7%
Pleural TB total
Sensitivity 74% 51.9% 61.7% 50% 44.8% 40.2%
Speciﬁcity 100% 100% 96% 100% 96% 100%
PPV 100% 100% 97.9% 100% 97.2% 100%
NPV 55.6% 40.3% 44.9% 39.4% 36% 35.2%
TB, tuberculosis; PCR, polymerase chain reaction; IFN-g, interferon-gamma; ADA, adenosine deaminase; IgA, immunoglobulin A; PPV, positive predictive value; NPV,
negative predictive value.
Y. Kalantri et al. / International Journal of Infectious Diseases 15 (2011) e226–e231 e2294. Discussion
Tuberculous pleuritis remains one of themajor causes of pleural
effusion in many countries.25,26 AFB smear, culture, and histology
of biopsy specimens remain the gold standards for the diagnosis of
pleural TB, and thesewere used in the deﬁnition of conﬁrmed cases
in the present study.
The present study was based on 204 consecutive pleural
effusion cases referred to the Microbiology Department of
Choithram Hospital and Research Centre. The hospital is a tertiary
care and reference center. The following clinical details were taken
into account at the time of data analysis: radiological ﬁndings,
laboratory ﬁndings, and follow-up data. The diagnosis of conﬁrmed
tuberculous pleural effusion was based on AFB smear, culture, or
histological features of the pleural biopsy specimen. It should be
mentioned that patients are often unwilling to give consent for
pleural biopsy, and as a result pleural biopsy specimens were
available for only relatively few cases at our end. Themost difﬁcult
group in the present study was the non-TB disease cases.
Malignancy was diagnosed in 27 of the 50 non-TB cases, but
surprisingly only 12 of the 27 had exudative effusion, while 15 had
transudative effusion. It is difﬁcult to offer an explanation for this
observation. Similarly, only a few cases of rheumatoid arthritis and
two of systematic lupus erythematosis also had transudative
pleural effusion. Further, details of the above-mentioned cases
were limited and hence it appears that the etiology other than TBwas not well established in some of the cases in the non-TB group.
Diagnostic tap of pleural ﬂuid for congestive cardiac failure is not
usually done in our area. The three cases of congestive cardiac
failure included in the present series also had a history of chronic
cough and hence the clinicians had carried out the diagnostic tap.
Some of the cases in the non-TB pleural effusion group could be of
unknown origin.
INF-g, a cytokine associated with the Th1 type of cell-mediated
immune response, was found to be closely associated with the
tuberculous etiology of pleural effusion. It is likely that IFN-g
detected in pleural ﬂuid may arise from stimulation of T
lymphocytes by tubercular antigens. The ROC analysis clearly
demonstrated IFN-g to be the most sensitive and speciﬁc among
the different diagnostic markers studied. Further, high sensitivity,
speciﬁcity, predictive values, and positive likelihood ratios were
observed for IFN-g in the conﬁrmed and probable pleural TB
groups, which points to a high diagnostic potential for the test.
These ﬁndings are consistent with the published reports on the
presence of high levels of IFN-g in the pleural ﬂuid of patients with
pleural TB.9–12
Real-time PCR-based ﬂuorescence assays have advantages over
conventional PCR with respect to sensitivity, speciﬁcity, and
reduction in time to results.27,28 In the present study, real-time PCR
had a high speciﬁcity, but lower sensitivity when compared to IFN-
g and ADA. False-negative results by real-time PCR can be
explained by the presence of low numbers of TB bacilli in the
Y. Kalantri et al. / International Journal of Infectious Diseases 15 (2011) e226–e231e230pleural TB samples. One sample that was associated with
neoplastic involvement of the pleura was positive by real-time
PCR; however this patient had a prior history of TB (15 years back).
In our study, real-time PCR using the 16S rRNA sequence showed
an improvement in performance outcome in comparison to other
studies .12,18,19
ADA is an enzyme involved in purine catabolism, found in the
majority of cells, but particularly in lymphocytes. It has been
reported to have high sensitivity and reasonably good speciﬁcity
for the diagnosis of pleural TB.11–15 Since measurement of ADA is
simple and inexpensive, it has a great diagnostic potential in the
diagnosis of pleural TB in developing countries. In our study, the
measurement of ADA activity showed good sensitivity; however
four of the non-TB pleural ﬂuid samples had increased ADA. These
false-positive results were observed in three patients with
malignancies and in one with bacterial pneumonia.
IgAbeinga secretoryantibody is likely tobepresent in thepleural
ﬂuid and may prove to have diagnostic value. Kaisermann et al.20
and Alifano et al.23 showed good sensitivity of IgA in their studies.
However in the present study, the sensitivity and speciﬁcity of IgA
were low when compared to the other parameters.
Real-time PCR, IFN-g, ADA, and IgA measurements have been
evaluated individually and in various combinations.11–20 However,
the combination of real-time PCR, IFN-g, ADA, and IgA measure-
ment together has not previously been explored. In the present
study, IFN-g appeared to be themost sensitive among the different
diagnostic tests.
The measurement of ‘either IFN-g or real-time PCR’ yielded the
highest sensitivity of 100% in the conﬁrmed pleural TB group and
96.2% in the probable TB group; speciﬁcity was 94% in both the
conﬁrmed and probable TB groups. The combination of ‘both IFN-g
and ADA’ showed the highest sensitivity (92%) and speciﬁcity
(100%) in the conﬁrmed pleural TB group, with 65.4% sensitivity
and 100% speciﬁcity in the probable TB group.
A somewhat similar approach was used by Villegas et al.12 for
the diagnosis of pleural TB using ADA, IFN-g, and PCR. Their
ﬁndings showed that both IFN-g and PCRwhen combinedwith the
determination of ADA yielded a high sensitivity (89.7% and 90.2%,
respectively) for conﬁrmed and probable pleural TB combined
cases, whereas IFN-g in combination with ADA activity presented
the highest speciﬁcity (83.8%). Lima et al.19 also showed the
sensitivities of PCR and ADA when used alone to be 31.3% and
68.8%, respectively, whereas PCR or ADA combined showed an
increased sensitivity of 87.5%. Ghanei et al.29 examined a
statistical approach to the diagnosis of pleural TB by combining
the diagnostic efﬁciency of ADA, pleural ﬂuid protein, lactate
dehydrogenase, and lymphocyte to neutrophil ratio. Their
observations showed that the lymphocyte to neutrophil ratio
combined with the determination of ADA yielded a sensitivity of
91.7%, whereas the combination of pleural ﬂuid protein levels with
ADA presented a high speciﬁcity of 82.1%.
Our study and the other studies12,19,29 reveal that the
combination of two tests, with a positive result by either of the
tests, increases the diagnostic sensitivity for all individual tests,
whereas the condition of positivity for both methods increases
speciﬁcity at the cost of a reduction in sensitivity. A predictive
model for the diagnosis of pleural TB in the population of Rio de
Janeiro was used by Neves et al.,30 using ADA, total leukocytes,
percentile of lymphocytes, protein level, lactate dehydrogenase,
duration of disease, age, and gender. However their study lacked
important diagnostic parameters like IFN-g and PCR.
In the present study we used the unstimulated interferon test
rather than the T-cell interferon test, and both the sensitivity and
speciﬁcity of the test were high. The high accuracy of the
unstimulated interferon gamma test over the T-cell assay has
recently been reported by Dheda et al.31With regard to cost, real-time PCR was the most expensive in
our set-up. Further, the expertise required and facility of real-time
PCR cause difﬁculties for economically developing countries,
which carry a heavy burden of TB. The IFN-g assay and IgA tests
are less expensive than PCR, and the ELISA test facility is available
in most microbiology laboratories. As individual tests, the
sensitivity of IFN-g was higher than that of real-time PCR, while
the speciﬁcitywasmarginally higher for real-time PCR. Thus, IFN-g
appears to be a good stand-alone test for the diagnosis of pleural
TB.
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